# Ivermectin

## Soolantra cream 1% 30gm

| 藥物代碼           | ESOO3                                                                                                                                                                                                                                     |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Rosacea (Soolantra cream): Treatment of inflammatory lesions of rosacea in adult patients.                                                                                                                                                |
| 副作用             | 1% to 10%:Central nervous system: Localized burning (<=1%)Dermatologic: Skin irritation (<=1%)<1% (Limited to important or life-threatening): Conjunctivitis, eye irritation, ocular hyperemia, seborrheic dermatitis of scalp, xeroderma |
| 禁忌               | Hypersensitivity (rare).                                                                                                                                                                                                                  |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                      |
| 用法用量           | Apply to each affected area (eg, forehead, chin, nose, each cheek) once daily.                                                                                                                                                            |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                              |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                              |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                  |
| 孕期用藥建議       | Human data suggest low risk                                                                                                                                                                                                               |
| 附帶說明           | N/A                                                                                                                                                                                                                                       |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                       |
| 附帶說明           | N/A                                                                                                                                                                                                                                       |
| 注射劑給藥建議途徑 | EXT                                                                                                                                                                                                                                       |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                       |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                       |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                       |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                       |
| 注意事項           | N/A                                                                                                                                                                                                                                       |

## Stromectol 3mg

| 藥物代碼           | OSTRM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Scabies, Onchocerciasis, Intestinal strongyloidiasis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 副作用             | CommonDermatologic: Pruritus (2.8% ), Urticaria (Oral, 0.9% )Neurologic: Dizziness (2.8% )SeriousImmunologic: Mazzotti reactionNeurologic: Seizure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 禁忌               | Hypersensitivity to oral ivermectin or any other component of the product. Specific contraindications have not been determined for topical ivermectin.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 藥物保存方式       | 攝氏30度C以下                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 用法用量           | Scabies: Oral: 200 mcg/kg as a single dose, dose could follow (3mg/tab): 15-24kg:1tab; 25-35kg:2tab; 36-50kg:3tab; 51-65kg:4tab; 66-79kg:5tab; >=80kg:200 mcg/kg. If the symptoms of infection are still present and the test is positive, Could be administered again after 8-15 days. Onchocerciasis: Oral: 200 mcg/kg as a single dose, dose could follow (3mg/tab): 15-24kg:1tab; 25-35kg:2tab; 36-50kg:3tab; 51-65kg:4tab; 66-79kg:5tab; >=80kg:200 mcg/kg. Intestinal strongyloidiasis: Oral: 200 mcg/kg as a single dose, dose could follow (3mg/tab): 15-24kg:1tab; 25-35kg:2tab; 36-50kg:3tab; 51-65kg:4tab; 66-79kg:5tab; >=80kg:200 mcg/kg. |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 附帶說明           | [仿單]因目前尚未有ivermectin使用在孕婦的安全性報告，孕婦應勿使用ivermectin。 分別投予口服劑量 0.4 和 10 毫克/公斤/天的 ivermectin，會導致小鼠和大鼠顎裂， 投予口服劑量 3 毫克/公斤/天的 ivermectin，會導致兔子顎裂和前爪內翻。                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 附帶說明           | [仿單]Ivermectin 會排泄於乳汁中，對新生兒之安全性尚未建立。在大鼠，控制組的幼鼠及在子宮內曾接受暴露的幼鼠， 與治療過的母鼠進行交叉飼養，皆觀察到降低幼鼠之存活率。然而在控制組幼鼠及在子宮內曾接受暴露的 幼鼠，與控制組母鼠進行交叉飼養下，則皆未發現幼鼠之存活率降低現象。 只有在治療母親的效益超越餵哺母乳之嬰兒所可能面臨之風險的情況下，才可對授乳母親投予本藥， 且準備為嬰兒餵哺母乳的母親應延後到嬰兒出生至少 1 週後再進行治療。                                                                                                                                                                                                                 |
| 注射劑給藥建議途徑 | AC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

